Ameet Nathwani

With more than 25 years of experience in the pharmaceutical industry, Ameet was most recently an Executive Committee member at Sanofi SA, where he served as Chief Medical Officer, Head of Medical, and Chief Digital Officer and was responsible for enhancing Sanofi’s strategy to integrate digital technologies and medical science to ultimately improve patient outcomes.

Prior to joining Sanofi, Ameet was the Global Head of Medical Affairs and a member of the Pharma Executive Committee at Novartis Pharma AG, where he led the establishment of a Real World Evidence Center of Excellence and Digital Medicine capabilities. Over his 11 years at Novartis, Ameet held a number of senior development and commercial positions including the Global Head of the Critical Care Business Franchise, Senior Vice President, and Global Development Head of the Cardiovascular and Metabolic Franchise. Prior to joining Novartis, Ameet held senior roles in R&D at GlaxoSmithKline, SmithKline Beecham, and Glaxo Group Research in both the UK and US.

Across his career in R&D, Ameet has been responsible for the development of over twenty drugs, four of which went on to become blockbusters.

Ameet earned his medical degree from the University of London, specialized in cardiology and intensive care medicine, and holds a Masters in Business Administration.